TCL Archive Phase III Tecemotide Trial Fails OS Endpoint; Second Trial Planned After Subgroup Analysis December 27, 2013
TCL Archive The Cancer Letter Obtains “Confidential” Documents From Duke IRB Investigation May 14, 2010